As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Reforms streamline processes without diluting safeguards, says Aboli Sunil Naravane, MD, IPICOL

A new India-EU free trade agreement promises to boost Indian pharmaceutical exports. Lower tariffs will make Indian medicines more competit...

Union Health Minister JP Nadda is working on a solution for the pharmaceutical industry. Drug regulator and department of pharmaceuticals a...

The Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new manufacturing quali...

A pharma group is requesting more time for manufacturers to meet new quality standards. Many companies have started upgrades but face genui...

Himachal Pradesh's drug regulation bodies came across a concerning trend: numerous pharmaceutical companies were found to be operating illi...

Many small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades a...

The state drug regulators have been asked to submit monthly reports to the Central Drugs Standard Control Organisation on the inspections a...

New bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...

Despite global challenges, Indian MSME exports have surged threefold between 2020-21 and 2024-25, reaching INR 12.39 lakh crore.

Small and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...

Quality norms should be designed to support MSMEs rather than stifle their growth, say industry leaders.

The revised Schedule M, which is considered more stringent than the World Health Organization's (WHO) good manufacturing practices (GMP) in...

In a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of ...

While challenges persist, the compliance levels of Indian MSMEs in terms of export have been gradually improving, say experts.

One of the focus areas of the policy, he said, is to develop an enabling ecosystem for technology adoption and innovation. The policy, the ...